This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
India’s pharmaceutical industry is a global powerhouse. It is already a massive $50 billion market and is projected to grow to $130 billion by 2030. With a similar rationale, large healthcare buyers (like global pharmaceuticalcompanies, retailers, medical chains, etc.)
According to the World Health Organization, the world will need more than 40 million new doctors, nurses, frontline healthcare workers, and various other healthcare professionals by 2030. This has not escaped the notice of pharmaceuticalcompanies looking to educate patients on topics, with which they may not have the most health literacy.
“As pipelines shift towards biotechnology, all companies will have to decide between investing in expertise in-house and relying on the pre-existing technological platforms offered by experienced companies.”. The rise of biologics.
All traditional small molecule pharmaceuticals include carbon building blocks – by definition, organic materials – which are then transformed via modern synthetic chemistry to assemble the complex and highly variable skeletons that the final target structures demand. So, when could the goal of a net zero pharmaceutical industry be achieved?
There has been an amendment under income tax provisions to disallow such expenses incurred by pharmaceuticalcompanies in violation of MCI regulations. – million nurses/midwives in the total stock by 2030. A recent WHO report estimated a shortage of about 1.8 million doctors and 0.65
Private Equity investors are both interested and invested in the health and weight loss market, including nutrition supplements, lifestyle (diet) companies such as Weight Watchers, packaged food and beverage products that we see in supermarkets and drug chains, and the fitness industry, including fitness centers and products such as Peloton.
Pharmaceuticalcompanies need to be prepared to answer the call for increased demand and supply into new markets, ensuring the proper resources and logistics framework are in place. In addition, a paper published in 2019, concluded that the pharmaceutical industry produced 48.55
With its highly educated, English-speaking workforce and high-quality medical facilities system, Singapore has attracted leading pharmaceuticalcompanies to open their regional headquarters in the city-state, including Novo Nordisk (Bagsvaerd, Denmark) and GSK. Additionally, Merck & Co.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content